Ypso-Facto, a Nancy, France-based company specializing in the design of chemical and biotechnological processes, received a €500k grant.
Bpifrance (the French Public Investment Bank) and the Grand Est Region provided the grant as part of the ‘Investments for the Future Program’.
The new investment will be used to further develop Ypso-Proxima®, the company’s existing general process design and evaluation software, by addressing the needs of the various players in the fine chemicals and biotechnology sectors.
The software will enable users to combine experimental information with numerical simulation, with an option to add intuitive user capabilities, in order to design efficient processes.
The new investment is in line with the development plans of the company, which had already marketed ChromWorksTM, a software application for chromatographic processes, in 2015.
In addition, Ypso-Facto launched an innovation program of €1.5m at the end of 2016, aimed at developing simulation software adapted to fine chemicals and biotechnologies, allowed the design of Ypso-Proxima®, the development of which will be continued ahead of the commercial launch scheduled for the second half of 2019.
Led by Roger-Marc Nicoud, founder and president, Ypso-Facto has already gathered a 50-client portfolio, mainly constituted of medium-sized companies and major international players.